naproxen

(redirected from Vimovo)
Also found in: Thesaurus, Medical, Encyclopedia.

na·prox·en

 (nə-prŏk′sən)
n.
A nonsteroidal anti-inflammatory drug, C14H14O3, used to treat fever and pain.

[Shortening and alteration of methoxynaphthylpropionic acid, one of its chemical names.]

naproxen

(nəˈprɒksɛn)
n
(Pharmacology) a drug with anti-inflammatory and pain-relieving properties

na•prox•en

(nəˈprɒk sən)

n.
a nonsteroidal anti-inflammatory substance, C14H14O3.
[by shortening and rearrangement of methoxy-, naphthyl-, and propionic, components of one of its chemical names]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.naproxen - a nonsteroidal anti-inflammatory drug (trade name Naprosyn) used in the treatment of arthritis and musculoskeletal inflammation and moderate pain
nonsteroidal anti-inflammatory, nonsteroidal anti-inflammatory drug, NSAID - an anti-inflammatory drug that does not contain steroids; "NSAIDs inhibit the activity of both Cox-1 and Cox-2 enzymes"
propanoic acid, propionic acid - a liquid fatty acid found in milk and sweat and in fuel distillates
Translations

naproxen

n naproxeno
References in periodicals archive ?
M2 EQUITYBITES-March 31, 2017-Horizon Pharma plc awarded Notice of Allowance in the US for VIMOVO (naproxen/esomeprazole) delayed release tablets
M2 PHARMA-March 31, 2017-Horizon Pharma plc awarded Notice of Allowance in the US for VIMOVO (naproxen/esomeprazole) delayed release tablets
Pozen also has two commercial pain products, Vimovo and Treximet, which are marketed by partners worldwide.
The Journal cites similar increases for Ofirmev pain injections and Vimovo pain tablets after new companies acquired the rights.
Horizon's portfolio already includes Vimovo, which is approved as a treatment for symptoms of osteoarthritis and rheumatoid arthritis, stated Walbert.
04% Retin-A Micro Gel Fenofibric Acid Delayed-Release Trilipix Delayed- Capsules, 45 mg, 135 mg Release Capsules Metformin Hydrochloride Extended-Release Glumetza Tablets USP, 500 mg, 1,000 mg Tablets Donepezil Hydrochloride Tablets, 23 mg Aricept Tablets AUGUST 2013 Bupropion Hydrobromide Extended-Re- Aplenzin IeaseTablets,174 mg, 522 mg Extended Release Tablets Naproxen and Esomeprazole Magnesium Vimovo Delayed- Delayed-ReleaseTablets, 375 mg/20 mg Release Tablets (base), 500 mg/20 mg (base) Norethindrone and Ethinyl Estradiol Tablets Ovcon-50 USP, 1 mg/0.
The PPI products listed in the communication are AcipHex (rabeprazole sodium); Dexi-lant (dexlansoprazole); Nexium (esomeprazole magnesium); omeprazole over-the-counter (OTC); Prevacid (lansoprazole) and OTC Prevacid 24hr; Prilosec (omeprazole) and its OTC product, Protonix (pantoprazole sodium); Vimovo (esomeprazole magnesium and naproxen); and Zegerid (omeprazole and sodium bicarbonate) and its OTC product.
The PPI products listed in the communication are AcipHex (rabeprazole sodium); Dexilant (dexlansoprazole); Nexium (esomeprazole magnesium); omeprazole over-the-counter (OTC);Prevacid (lansoprazole) and OTC Prevacid 24hr; Prilosec (omeprazole) and its OTC product, Protonix (pantoprazole sodium); Vimovo (esomeprazole magnesium and naproxen); and Zegerid (omeprazole and sodium bicarbonate) and its OTC product.
26 April 2011 - AstraZeneca plc (LON: AZN) (STO: AZN) and Pozen Inc (NASDAQ: POZN) have filed a patent infringement lawsuit in the USA against India-based generic drug maker Dr Reddy's Laboratories Ltd (NYSE: RDY) for anti-arthritis tablet Vimovo.
Among these drugs are Prilosec OTC, Zegerid OTC and Prevacid 24HR, and the prescription PPIs Nexium, Dexiland, Prilosec, Zegerid, Prevacid, Protonix, Aciphex and Vimovo.
risk of of low-dose aspirin-associated peptic ulcers), but Vimovo, a
M2 EQUITYBITES-March 15, 2016-Horizon Pharma reports US Patent and Trademark Office's additional notice of allowance for VIMOVO (naproxen/esomeprazole) delayed release tablets